DFTX Definium Therapeutics, Inc.
Nasdaq · SEC CIK 1813814 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $5.13M 15 sales by 5 insiders
- Filings on record
- 162 since 2022-01-19, latest 2026-09-18 21:55
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Barrow Robert | CEO, Dir | — | $3.08M |
| Sullivan Mark | CLO | — | $1.04M |
| Karlin Daniel | Chief Medical Off | — | $748.9K |
| Roberts Brandi | CFO | — | $135.7K |
| Wiley Matthew T. | Chief Commercial Off | — | $129.1K |
| Adsett Roger | Dir | — | — |
| CRYSTAL ROGER | Dir | — | — |
| Bruhn Suzanne Louise | Dir | — | — |
| Krebs Andreas | Dir | — | — |
| Vallone Carol A | Dir | — | — |
Transactions 145
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-22 | 2022-12-21 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $2.69 | -3,861 | 247.2K | -2% | -$10.4K | |
| 2022-12-22 | 2022-12-21 | DFTX | Karlin Dan | Chief Medical Off | S - Sale | $2.69 | -1,211 | 264.1K | -0.5% | -$3,258 | |
| M | 2022-10-27 | 2022-10-25+ | DFTX | Karlin Dan | Chief Medical Off | S - Sale | $2.91 | -1,185 | 265.3K | -0.4% | -$3,452 |
| 2022-10-25 | 2022-10-25 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $2.81 | -1,207 | 251.1K | -0.5% | -$3,392 | |
| 2022-10-18 | 2022-10-18 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $3.11 | -1,220 | 252.3K | -0.5% | -$3,794 | |
| M | 2022-09-27 | 2022-09-26+ | DFTX | Karlin Dan | Chief Medical Off | S - Sale | $5.70 | -1,205 | 267.1K | -0.4% | -$6,870 |
| 2022-09-27 | 2022-09-26 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $5.51 | -1,264 | 253.5K | -0.5% | -$6,965 | |
| 2022-09-19 | 2022-09-16 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $7.26 | -1,350 | 254.8K | -0.5% | -$9,801 | |
| 2022-09-01 | 2022-08-31 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $11.67 | -1,228 | 256.1K | -0.5% | -$14.3K | |
| 2022-09-01 | 2022-08-31 | DFTX | Karlin Dan | Chief Medical Off | S - Sale | $11.67 | -1,204 | 267.7K | -0.4% | -$14.1K | |
| 2022-08-17 | 2022-08-16 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $0.68 | -20.4K | 3.86M | -0.5% | -$13.8K | |
| D | 2022-08-15 | 2022-08-11 | DFTX | CRYSTAL ROGER | Dir | A - Grant | $0.00 | +89.3K | 89.3K | New | $0 |
| D | 2022-08-15 | 2022-08-11 | DFTX | Bruhn Suzanne Louise | Dir | A - Grant | $0.00 | +89.3K | 89.3K | New | $0 |
| M | 2022-07-27 | 2022-07-25+ | DFTX | Karlin Dan | Chief Medical Off | S - Sale | $0.69 | -18.2K | 4.03M | -0.4% | -$12.6K |
| 2022-07-26 | 2022-07-25 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $0.69 | -18.7K | 3.88M | -0.5% | -$12.9K | |
| 2022-07-18 | 2022-07-18 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $0.7 | -19.4K | 3.90M | -0.5% | -$13.6K | |
| 2022-06-28 | 2022-06-27 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $0.7 | -36.8K | 3.92M | -0.9% | -$25.7K | |
| 2022-06-28 | 2022-06-27 | DFTX | Karlin Dan | Chief Medical Off | S - Sale | $0.7 | -26.2K | 4.05M | -0.6% | -$18.4K | |
| 2022-06-21 | 2022-06-16 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $0.7 | -21.3K | 3.96M | -0.5% | -$14.9K | |
| DA | 2022-06-06 | 2022-06-01 | DFTX | Makes Brigid | Dir | A - Grant | $0.00 | +64.7K | 158.7K | +69% | $0 |
| DA | 2022-06-06 | 2022-06-01 | DFTX | Krebs Andreas | Dir | A - Grant | $0.00 | +21.6K | 21.6K | New | $0 |
| DA | 2022-06-06 | 2022-06-01 | DFTX | Vallone Carol A | Dir | A - Grant | $0.00 | +43.1K | 43.1K | New | $0 |
| DA | 2022-06-03 | 2022-05-23 | DFTX | Greenway Schond L. | CFO | A - Grant | $0.00 | +1.27M | 1.27M | New | $0 |
| D | 2022-06-03 | 2022-06-01 | DFTX | Makes Brigid | Dir | A - Grant | $0.00 | +64.7K | 158.7K | +69% | $0 |
| D | 2022-06-03 | 2022-06-01 | DFTX | Vallone Carol A | Dir | A - Grant | $0.00 | +43.1K | 43.1K | New | $0 |
| D | 2022-06-03 | 2022-06-01 | DFTX | Krebs Andreas | Dir | A - Grant | $0.00 | +21.6K | 21.6K | New | $0 |
| 2022-05-31 | 2022-05-27 | DFTX | Karlin Dan | Chief Medical Off | S - Sale | $0.82 | -9,555 | 4.08M | -0.2% | -$7,835 | |
| 2022-05-26 | 2022-05-25 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $0.77 | -18.4K | 3.98M | -0.5% | -$14.2K | |
| 2022-05-26 | 2022-05-25 | DFTX | Karlin Dan | Chief Medical Off | S - Sale | $0.77 | -8,242 | 4.09M | -0.2% | -$6,346 | |
| 2022-05-24 | 2022-05-11 | DFTX | Makes Brigid | Dir | J - Other | $0.00 | +67.7K | 94.0K | +257% | $0 | |
| D | 2022-05-23 | 2022-05-23 | DFTX | Greenway Schond L. | CFO | A - Grant | $0.00 | +1.27M | 1.27M | New | $0 |
| A | 2022-05-19 | 2022-05-18 | DFTX | Barrow Robert | CEO, Dir | S - Sale | $0.71 | -18.9K | 4.00M | -0.5% | -$13.5K |
| 2022-05-17 | 2022-05-15 | DFTX | Barrow Robert | CEO, Dir | F - Tax | $0.82 | -18.9K | 4.00M | -0.5% | -$15.5K | |
| 2022-04-27 | 2022-04-26 | DFTX | Karlin Dan | Chief Medical Off | F - Tax | $0.81 | -13.0K | 4.10M | -0.3% | -$10.6K | |
| 2022-04-19 | 2022-04-18 | DFTX | Barrow Robert | CEO, Dir | F - Tax | $0.92 | -19.1K | 4.01M | -0.5% | -$17.6K | |
| 2022-03-29 | 2022-03-28 | DFTX | Karlin Dan | Chief Medical Off | F - Tax | $1.17 | -10.2K | 4.11M | -0.2% | -$11.9K | |
| D | 2022-03-28 | 2022-03-24 | DFTX | Karlin Dan | Chief Medical Off | A - Grant | $0.00 | +950.0K | 4.12M | +30% | $0 |
| D | 2022-03-28 | 2022-03-24 | DFTX | Wernli Miri Halperin | Executive Pres, Dir | A - Grant | $0.00 | +600.0K | 1.27M | +89% | $0 |
| D | 2022-03-28 | 2022-03-24 | DFTX | Barrow Robert | CEO, Dir | A - Grant | $0.00 | +1.82M | 4.03M | +82% | $0 |
| D | 2022-03-28 | 2022-03-24 | DFTX | Hu Cynthia W. | CLO, Sec | A - Grant | $0.00 | +1.20M | 1.20M | New | $0 |
| 2022-03-17 | 2022-03-15 | DFTX | Barrow Robert | CEO, Dir | F - Tax | $1.00 | -12.6K | 2.21M | -0.6% | -$12.6K | |
| D | 2022-03-14 | 2022-02-10 | DFTX | Liao Carrie | VP, Ctrl, Acct Principal | A - Grant | $0.00 | +403.4K | 403.4K | New | $0 |
| 2022-03-01 | 2022-02-26 | DFTX | Karlin Dan | Chief Medical Off | F - Tax | $1.21 | -118.1K | 3.17M | -4% | -$143.0K | |
| 2022-02-17 | 2022-02-15 | DFTX | Barrow Robert | CEO, Dir | F - Tax | $1.35 | -18.7K | 2.23M | -0.8% | -$25.3K | |
| 2022-01-19 | 2022-01-15 | DFTX | Barrow Robert | CEO, Dir | F - Tax | $1.05 | -190.3K | 2.24M | -8% | -$199.8K |
Purchase Sale Sale after option exercise All abbreviations